Legal Challenges to State Drug Pricing Laws

JAMA. 2018 Mar 6;319(9):865-866. doi: 10.1001/jama.2017.20952.

Authors

Theodore T Lee¹, Aaron S Kesselheim², Amy Kapczynski³

Affiliations

¹ Yale Law School, Yale University, New Haven, Connecticut.
² Program On Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Collaboration for Research Integrity and Transparency (CRIT), Yale Law School, New Haven, Connecticut.

PMID: 29435585
DOI: 10.1001/jama.2017.20952

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Drug Costs / legislation & jurisprudence*
Drug Industry / legislation & jurisprudence*
Federal Government
Fees, Pharmaceutical / legislation & jurisprudence
Government Regulation
Legislation, Drug
Patents as Topic / legislation & jurisprudence
State Government*
United States